YOUR ADULT PATIENTS’ PROGRESS MAY BE CUT SHORT BY RSV1

 

Older adult patients, including those with certain comorbidities, are at an increased risk of severe RSV1

 

RSV is a common and contagious respiratory virus that can cause lower respiratory tract disease (LRTD), including complications such as pneumonia and exacerbations of COPD, asthma, and CHF.1

Severe RSV can lead to hospitalization and even death2

Each year in the United States
Approximately 177,000 adults aged 65 years or older are hospitalized due to RSV infection
Approximately 14,000 hospitalized adults die from RSV infection

Recognize the threat of severe RSV for older adult patients

EXPLORE MORE >

In a study conducted between January 2011 and June 2015 among patients aged 60 years or older hospitalized with RSV (N=645)3*:

43 percent of survivors were admitted for greater than or equal to 7 days
18% of survivors were admitted to the ICU
17% of survivors were readmitted within 30 days
  • *

    An observational, retrospective, cohort study conducted at an integrated health system evaluated adults aged ≥60 years hospitalized with RSV infection (n=645) or influenza infection (n=1878) over 5 consecutive seasons between January 2011 and June 2015 to compare demographics, prehospitalization characteristics, hospital utilization, and clinical outcomes.

See how severe RSV can impact patients

SEE THE DATA >

Patients aged 60 years and older who were hospitalized with RSV experienced serious clinical outcomes3

 

Rates of events during hospitalization among adults aged 60 years or older with RSV3†:

37.7%

Cardiovascular complications‡

18.9%

Acute renal failure

16.9%

Respiratory exacerbations§

  • †

    An observational, retrospective, cohort study conducted at an integrated healthcare system evaluated adults aged ≥60 years hospitalized with RSV infection (n=645) or influenza A/B infection (n=1878) over 5 consecutive seasons between January 2011 and June 2015 to compare demographics, prehospitalization characteristics, hospital utilization, and clinical outcomes. Patients with RSV had the following rates of comorbidities 1 year prior to admission: 32.2% had ischemic heart disease; 35.3% had CHF; 38.9% had diabetes; 29.8% had COPD, chronic bronchitis, or emphysema; 26.0% had asthma; and 5.6% had end-stage renal disease.

  • ‡

    Defined as myocardial infarction, pericarditis, endocarditis, myocarditis, or atrial fibrillation.

  • §

    Defined as exacerbation of COPD, chronic bronchitis, or emphysema.

Talk to your adult patients about the threat of severe RSV

SEE THE IMPACT >
Video thumbnail: See Irene's journey with RSVVideo Icon
Watch Now

See Irene’s journey with RSV

Hear Irene tell her own story of RSV.

Watch now >

CHF=chronic heart failure; COPD=chronic obstructive pulmonary disease; ICU=intensive care unit; RSV=respiratory syncytial virus.

References

  1. Respiratory syncytial virus infection (RSV). RSV in adults. Centers for Disease Control and Prevention. Accessed July 9, 2025. https://www.cdc.gov/rsv/adults/

  2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-1759. doi:10.1056/NEJMoa043951 

  3. Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197-203. doi:10.1093/cid/ciy991